Bacteria-enhanced graphene oxide nanoparticles provide triple-action tumor eradication
Modern cancer treatments have evolved beyond traditional chemotherapy to include targeted approaches such as immunotherapy, ...
Head and Neck Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...
The Scientist8h
Differentiating Macrophages from iPSCs
New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically ...